P
Peter Bannas
Researcher at University of Hamburg
Publications - 189
Citations - 3922
Peter Bannas is an academic researcher from University of Hamburg. The author has contributed to research in topics: Medicine & Magnetic resonance imaging. The author has an hindex of 29, co-authored 155 publications receiving 3102 citations. Previous affiliations of Peter Bannas include University of Yamanashi & University of Wisconsin-Madison.
Papers
More filters
Journal ArticleDOI
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
TL;DR: Recent developments and perspectives for applications of nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics are discussed.
Journal ArticleDOI
Feasibility of 18F-Sodium Fluoride PET/CT for Imaging of Atherosclerotic Plaque
Thorsten Derlin,Ulrich Richter,Peter Bannas,Philipp G. C. Begemann,Ralph Buchert,Janos Mester,Susanne Klutmann +6 more
TL;DR: The data indicate the feasibility of 18F-sodium fluoride PET/CT for the imaging of mineral deposition in arterial wall alterations and may provide relevant information about the morphologic and functional properties of calcified plaque.
Journal ArticleDOI
In Vivo Imaging of Mineral Deposition in Carotid Plaque Using 18F-Sodium Fluoride PET/CT: Correlation with Atherogenic Risk Factors
Thorsten Derlin,Christian Wisotzki,Ulrich Richter,Ivayla Apostolova,Peter Bannas,Christoph Weber,Janos Mester,Susanne Klutmann +7 more
TL;DR: Carotid 18F-sodium fluoride uptake is a surrogate measure of calcifying carotid plaque, correlates with cardiovascular risk factors, and is more frequent in patients with a high-risk profile for atherothrombotic events but demonstrates a weaker correlation with risk factors than does calcified plaque burden.
Journal ArticleDOI
Extracellular NAD and ATP: Partners in immune cell modulation.
Friedrich Haag,Sahil Adriouch,Anette Braß,Caroline Jung,Sina Möller,Felix Scheuplein,Peter Bannas,Michel Seman,Friedrich Koch-Nolte +8 more
TL;DR: P2X7-mediated NAD-induced cell death (NICD) specifically targets this cell population and may inhibit bystander activation of unprimed T cells, reducing the risk of autoimmunity and augment an immune response.
Journal ArticleDOI
Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation.
Welbeck Danquah,Catherine Meyer-Schwesinger,Björn Rissiek,Carolina Pinto,Arnau Serracant-Prat,Miriam Amadi,Domenica Iacenda,Jan-Hendrik Knop,Anna Hammel,Philine Bergmann,Philine Bergmann,Nicole Schwarz,Joana Assuncao,Wendy Rotthier,Friedrich Haag,Eva Tolosa,Peter Bannas,Eric Boué-Grabot,Tim Magnus,Toon Laeremans,Catelijne Stortelers,Friedrich Koch-Nolte +21 more
TL;DR: The results show that nanobody technology can generate potent, specific therapeutics against ion channels, confirm P2x7 as a therapeutic target for inflammatory disorders, and characterize a potent new drug candidate that targets P2X7.